The NORD trial: Needle aspiration OR chest Drain insertion for pneumothorax in newborns
ISRCTN | ISRCTN65161530 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN65161530 |
Secondary identifying numbers | NVD001 |
- Submission date
- 23/07/2013
- Registration date
- 15/08/2013
- Last edited
- 30/05/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Neonatal Diseases
Plain English summary of protocol
Background and study aims
Many babies have difficulty breathing after birth. Some of these babies have air collected between their chest wall and the outer surface of the lung. This collection of air is called a pneumothorax. If doctors believe that a pneumothorax is making it difficult for babies to breathe, they remove the air. Most doctors do this by inserting a drain through the chest wall and leaving it in place. Some doctors insert a needle to suck out the air which they then remove. Many infants who have their pneumothorax removed with a needle go on to have a chest drain inserted. It is not known whether it is preferable to do the chest drain immediately or to attempt needle insertion. In this study, we will find this out.
Who can participate?
Newborn babies who are receiving breathing support and have pneumothorax
What does the study involve?
Babies will be randomly allocated to have their pneumothorax drained either by needle aspiration or with a chest drain. We will determine how many infants in both groups ultimately have a chest drain insertion. All babies will be followed up until they get discharged from the hospital.
What are the possible benefits and risks of participating?
Both needle aspiration and chest drain insertion are well-accepted methods of draining a pneumothorax. There are no additional risks (above those already encountered by a baby who is receiving breathing support and who is having a pneumothorax drained) by participating in the study. Babies will not have additional tests because they are participating in the study. Fewer infants may have chest drains inserted by participating in the study.
Where is the study run from?
This study run from The National Maternity Hospital, Dublin, Ireland
When is the study starting and how long is it expected to run for?
The study starts in August 2013 and is expected to last for one year
Who is funding the study?
The National Childrens Research Centre, Dublin, Ireland
Who is the main contact?
Dr Colm ODonnell
codonnell@nmh.ie
Contact information
Scientific
Neonatal Intensive Care Unit
The National Maternity Hospital
Holles Street
Dublin
2
Ireland
codonnell@nmh.ie |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
Scientific title | A randomised controlled trial of needle aspiration or chest drain insertion for pneumothorax in newborns |
Study acronym | NORD |
Study objectives | In newborn infants with symptomatic pneumothoraces, aspirating air with a needle reduces the need for chest drain insertion. |
Ethics approval(s) | Ethics Committee at the National Maternity Hospital, Dublin, 04/06/2013 |
Health condition(s) or problem(s) studied | Pneumothorax in newborn infants |
Intervention | Aspiration with a 23 or 25 gauge "butterfly" needle and 20mL syringe versus chest drain insertion. Acute intervention (up to 15 minutes). Follow-up until hospital discharge. |
Intervention type | Procedure/Surgery |
Primary outcome measure | Chest drain insertion for management of pneumothorax on chest x-ray within 6 hours of diagnosis. |
Secondary outcome measures | 1. Duration of chest drain 2. Number of chest drain insertions 3. Duration of ventilation post intervention 4. Duration of ventilation 5. Duration of nasal continuous positive airway pressure 6. Duration of supplemental oxygen 7. Bronchopulmonary dysplasia oxygen treatment at 28 days 8. Chronic lung disease oxygen treatment at 36 weeks post menstrual age 9. Nosocomial infections 10. Pleural effusions 11. Duration of hospital stay 12. Death before discharge from hospital |
Overall study start date | 19/08/2013 |
Completion date | 30/06/2014 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Neonate |
Sex | Both |
Target number of participants | 70 |
Key inclusion criteria | Infants (term and preterm) will be eligible for enrolment in the study if they 1. Have a pneumothorax diagnosed on chest x-ray by treating clinicians 2. Are receiving respiratory support 2.1. Mechanical ventilation (conventional or high frequency oscillation) 2.2. Continuous positive airway pressure (CPAP) 2.3. Supplemental oxygen FiO2 > 40% by head box or nasal cannulae to keep SpO2 >90% 3. The treating clinicians deem the pneumothorax requires treatment |
Key exclusion criteria | Infants will be excluded from the study if they: 1. Do not have respiratory distress 2. Have significant pulmonary hypoplasia, e.g. Potter's sequence |
Date of first enrolment | 19/08/2013 |
Date of final enrolment | 30/06/2014 |
Locations
Countries of recruitment
- Australia
- Germany
- Ireland
- Italy
- Netherlands
- Norway
- Sweden
Study participating centre
2
Ireland
Sponsor information
Hospital/treatment centre
c/o Colm O'Donnell
Neonatal Intensive Care Unit
Holles Street
Dublin
2
Ireland
Website | http://www.nmh.ie/ |
---|---|
https://ror.org/03jcxa214 |
Funders
Funder type
Research organisation
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/07/2018 | Yes | No |
Editorial Notes
30/05/2018: Publication reference added.